Champions Oncology Analyst Ratings
Express News | Champions Oncology Inc : Craig-Hallum Raises Target Price to $8 From $6
Stocks to Watch: Adobe, Champions Oncology, DBV Technologies
Champions Oncology, Inc. (CSBR) Q2 2025 Earnings Call Transcript
Champions Oncology Shares Are Trading Higher After the Company Reported a Year-over-year Increase in Q2 Financial Results.
Earnings Flash (CSBR) CHAMPIONS ONCOLOGY Reports Q2 EPS $0.05, Vs. Street Est of $0.01
Express News | Champions Oncology Q2 Revenue USD 13.5 Million
Champions Oncology Reports Quarterly Revenue of $13.5 Million Adjusted EBITDA of $1.1 Million
Earnings Scheduled For December 11, 2024
A Peek at Champions Oncology's Future Earnings
Craig-Hallum Maintains Champions Oncology(CSBR.US) With Buy Rating
Analysts Offer Insights on Healthcare Companies: Inotiv (NOTV), Ascendis Pharma (ASND) and Champions Oncology (CSBR)
Champions oncology (CSBR.US) will release its financial report after hours on December 11.
$Champions Oncology(CSBR.US)$ will release its financial report after the market closes on December 11th. How were the previous performance results? In 2025Q1, revenue was $14.061 million, net income was $1.313 million, and earnings per share were $0.09 for $Champions Oncology(CSBR.US)$. For 2024Q2, revenue was $11.573 million, net income was -$-2.071 million, and earnings per share were -$0.15. The above data was prepared in accordance with US accounting standards.
Champions Oncology to Announce Second Quarter Financial Results on Wednesday, December 11, 2024
Champions Oncology (NASDAQ:CSBR) Shareholders Have Endured a 61% Loss From Investing in the Stock Three Years Ago
Champions Oncology Announces Agreement With Weill Cornell Medicine
Champions Oncology Inc (CSBR) Q4 2024 Earnings Call Highlights: Navigating Challenges and ...
Champions Oncology Inc (CSBR) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ...
Champions Oncology Announces Sudden Loss of President
Champions Oncology (NASDAQ:CSBR) Is In A Strong Position To Grow Its Business